This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2017
  • /
  • 10
  • /
  • FDA approval for Mako Total Knee with Triathlon Tr...
Drug news

FDA approval for Mako Total Knee with Triathlon Tritanium.- Stryker.

Read time: 1 mins
Last updated:20th Oct 2017
Published:20th Oct 2017
Source: Pharmawand

Stryker's Joint Replacement division announced that its cementless Mako Total Knee with Triathlon Tritanium has received 510(k) market clearance by the FDA .

Triathlon Tritanium combines the kinematics of Stryker's market leading Triathlon knee implant with the latest in highly porous biologic fixation technology for a knee system like no other. The innovation of Tritanium's tibial baseplate and metal-backed patella components are enabled by Stryker's proprietary AMagine additive manufacturing technology and are SOMA-designed. With cementless procedures rising in popularity and becoming a fast-growing trend, Mako Total Knee with Triathlon Tritanium expands the current robotics offering to provide a cementless solution for orthopaedic surgeons seeking a more predictable surgical experience combined with increased operating room efficiency, biologic fixation and an alternative to bone cement.

.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.